Drugs (Pharmaceuticals) – Page 32

US Agencies Start Inquiry Into Generic Drug Shortages

The F.T.C. and H.H.S. are examining the tactics of group purchasing organizations that generic industry executives say have led to scarce supplies of treatments like chemotherapy.

By Christina Jewett

Conflicts of Interest Courts and the Judiciary Decisions and Verdicts Drugs (Pharmaceuticals) Federal Courts (US) Food and Drug Administration Kacsmaryk, Matthew Medicine and Health Mifeprex (RU-486) Research Sage Publications Suits and Litigation (Civil) Supreme Court (US)

Journal Retracts Studies Cited in Federal Court Ruling Against Abortion Pill

The journal found that the studies, which had suggested that medication abortion is unsafe, included incorrect factual assumptions and misleading presentation of the data.

By Pam Belluck

Bristol Myers Squibb Company Drugs (Pharmaceuticals) Johnson & Johnson Merck & Company Inc Prices (Fares, Fees and Rates) Sanders, Bernard Senate Senate Committee on Health, Education, Labor and Pensions United States Politics and Government

J&J, Merck and Bristol Myers Squibb CEOs Will Testify at Senate Hearing on Drug Prices

The top executives of three major companies are set to appear on Thursday before a Senate panel led by Mr. Sanders, who has made lowering drug costs a signature issue.

By Noah Weiland and Rebecca Robbins

Content Type: Service Drugs (Pharmaceuticals) Elderly Eliquis (Drug) Federal Aid (US) Health Insurance and Managed Care Income Inflation Reduction Act of 2022 Medicare Personal Finances Prices (Fares, Fees and Rates) Retirement

Medicare Recipients Can Save on Drugs in 2024

Federal law set caps on some spending for seniors who are enrolled in Part D prescription drug plans. Those paying for high-cost medicines will benefit.

By Mark Miller